Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An extension study to evaluate the persistence of the immune responses induced by GSK Biologicals Zoster Vaccine, GSK324332A, administered in healthy adult subjects aged 18-30 years and 50-70 years.

Next Previous
X
Search
Trial Profile

An extension study to evaluate the persistence of the immune responses induced by GSK Biologicals Zoster Vaccine, GSK324332A, administered in healthy adult subjects aged 18-30 years and 50-70 years.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 05 Sep 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Varicella zoster virus glycoprotein vaccine (Primary) ; AS01B; Varicella zoster virus vaccine live
  • Indications Herpes zoster
  • Focus Pharmacodynamics
  • Sponsors GlaxoSmithKline; GSK

    • Most Recent Events

    • 08 Apr 2019 Results published in the Vaccine
    • 12 Oct 2008 Trial phase changed from I/II to II as reported by ClinicalTrials.gov.
    • 09 Sep 2008 Actual patient number (34) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top